Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Prostatic Neoplasms × abemaciclib × Clear all

Phase

Phase 2 3 Phase 1 3 Phase 3 1 Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 13 Brain Neoplasms 4 Neoplasm Metastasis 3 Ovarian Neoplasms 2 Glioma 2 Glioblastoma 2 Endometrial Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Triple Negative Breast Neoplasms 1 Solid Tumor, Adult 1 Sarcoma, Kaposi 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Osteosarcoma 1 Neuroblastoma 1 Neoplasms by Site 1 Neoplasms 1 Multiple Myeloma 1 Medulloblastoma 1 Lung Neoplasms 1 Liposarcoma 1 Leiomyosarcoma 1 Fallopian Tube Neoplasms 1 Ependymoma 1 ER+ HER2- Advanced Breast Cancer 1

Interventions

Docetaxel 27 Prednisone 22 enzalutamide 15 pembrolizumab 10 Abiraterone Acetate 9 gallium 68 PSMA-11 8 Radiotherapy 8 Pluvicto 8 Leuprolide 7 Nivolumab 6 Magnetic Resonance Spectroscopy 6 Estramustine 5 Biopsy 5 orteronel 4 olaparib 4 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 4 Specimen Handling 4 Radiotherapy, Intensity-Modulated 4 Granulocyte-Macrophage Colony-Stimulating Factor 4 Cyclophosphamide 4 Carboplatin 4 tremelimumab 3 durvalumab 3 darolutamide 3 cemiplimab 3 cabazitaxel 3 bicalutamide 3 avelumab 3 abiraterone 3 Radiosurgery 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05113537 2025-09-18

UPLIFT

University of California, San Francisco

Phase 1/2 Recruiting

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡